MSc in Pharmaceutical Regulatory Affairs
A specialised master’s programme preparing professionals for global drug, biologic, and medical device regulatory compliance.
Best for:Best for professionals in pharmaceutical operations, quality engineering, or regulatory affairs seeking to advance their careers with a specialised master’s degree in compliance and regulatory strategy.
Overview
This part-time master’s programme at SETU Carlow Campus offers an advanced understanding of pharmaceutical regulatory affairs, focusing on EU legislation and industry practices. Designed for working professionals, it equips students with the skills to navigate regulatory landscapes for drugs, biologics, and medical devices. The curriculum blends theoretical knowledge with practical insights, emphasising strategic compliance and industry networking. Graduates gain expertise to expand their career opportunities in regulatory affairs, pharmaceutical operations, or quality engineering. The programme also supports upskilling for professionals already in the field, leveraging prior learning recognition policies.
What you'll do
- Develop and implement global strategies for drug, biologic, and device development and evaluation.
- Apply principles of pharmaceutical sciences to drug and biologics discovery and development.
- Analyse and interpret current and proposed EU legislation to ensure regulatory compliance.
- Collaborate with industry experts to conduct research for a dissertation project.
- Expand professional networks within the pharmaceutical industry through coursework and industry interactions.
- Develop skills to take on broader job responsibilities in regulatory affairs and related fields.
Requirements
Degree required: A second-class honours degree (2.1 or equivalent) in science, engineering, quality, pharmaceutical sciences, regulatory affairs, or cognate areas. Alternatively, significant professional experience in pharmaceutical operations, quality engineering, device design, or mid-to-senior management roles may be considered with recognition of prior learning.
Degree offered: MSc in Pharmaceutical Regulatory Affairs
Language: English proficiency (assumed for applicants with a degree taught in English; no explicit test requirement mentioned).
Instruction: English
- Proven academic or professional experience in pharmaceutical, regulatory, or quality-related fields.
- Ability to analyse and interpret complex regulatory documentation.
- Strong communication and collaboration skills for industry interactions.
- Applicants must hold a second-class honours degree (2.1 or equivalent) in a relevant discipline, or demonstrate significant professional experience.
- Recognition of prior learning may apply to applicants with alternative qualifications or experience.
- No specific nationality or residency restrictions mentioned.
Funding & terms
Programme and admissions
Admissions not verified
A catalogue listing does not mean applications are open or funding is guaranteed. Check the source for your intake.
- Intake
- Not confirmed by the source
- Duration
- Not confirmed by the source
- Teaching language
- Not confirmed by the source
- Taught / research mode
- Not confirmed by the source
- Study mode
- Not confirmed by the source
- Campus
- Not confirmed by the source
- Prerequisites
- Not confirmed by the source
- Application instructions
- Not confirmed by the source
- Tuition
- Not confirmed by the source
- Funding
- Not confirmed by the source
How to apply
Deadline: 2026-08-28
Applicants must submit their application through the official SETU application portal. Required documents typically include academic transcripts, a CV, and a statement of purpose. Additional materials may be requested based on individual eligibility.
- CV
- Academic transcripts (Bachelor’s degree)
- Statement of purpose or personal statement
- Proof of English proficiency (if applicable)
- Letters of recommendation (if required)
Contact
Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.